Company Filing History:
Years Active: 1993
Title: Michael J Finnen: Innovating Essential Fatty Acid Treatments
Introduction: Michael J Finnen is a notable inventor based in Guildford, GB. His contributions to the field of biochemistry and medicine have led to advancements in the treatment of inflammation through innovative fatty acid therapies. With a focus on practical applications, Finnen's work is at the forefront of nutritional supplementation and pharmaceutical development.
Latest Patents: Finnen holds a patent for an essential fatty acid treatment. The patent describes a method of inhibiting phospholipase A2 in the control of inflammation. This process involves the administration of delta-6,9,12,15-octadecatetraenoic acid (stearidonic acid) and/or delta-8,11,14,17-eicosatetraenoic acid, either alone or in a pharmaceutically acceptable diluent or carrier. This innovative approach has the potential to significantly improve therapeutic options for individuals suffering from inflammatory conditions.
Career Highlights: Michael J Finnen is associated with Efamol Holdings Plc, a company that focuses on the research and development of essential fatty acids and their applications. Throughout his career, Finnen has dedicated himself to exploring the benefits of fatty acids in health and wellness, leading to groundbreaking discoveries that have enhanced understanding in the field.
Collaborations: In his professional journey, Finnen has collaborated with esteemed colleagues, including David F Horrobin. Their joint efforts have contributed to the exploration of new therapeutic avenues and the advancement of scientific knowledge regarding fatty acids.
Conclusion: Michael J Finnen's innovative work in the field of essential fatty acids demonstrates the profound impact that dedicated inventors can have on medicine and health. With his patent on inhibiting phospholipase A2, Finnen is not only contributing to scientific advancement but also helping pave the way for improved treatments for inflammation, showcasing the ongoing importance of innovation in the healthcare industry.